Found: 2

Select item for more details and to access through your institution.

  • Phase II trial of docetaxel, bevacizumab, lenalidomide and prednisone in patients with metastatic castration-resistant prostate cancer.

    Published in:
    BJU International, 2016, v. 118, n. 4, p. 590, doi. 10.1111/bju.13412
    By:
    • Madan, Ravi A.;
    • Karzai, Fatima H.;
    • Ning, Yang‐Min;
    • Adesunloye, Bamidele A.;
    • Huang, Xuan;
    • Harold, Nancy;
    • Couvillon, Anna;
    • Chun, Guinevere;
    • Cordes, Lisa;
    • Sissung, Tristan;
    • Beedie, Shaunna L.;
    • Dawson, Nancy A.;
    • Theoret, Marc R.;
    • McLeod, David G.;
    • Rosner, Inger;
    • Trepel, Jane B.;
    • Lee, Min‐Jung;
    • Tomita, Yusuke;
    • Lee, Sunmin;
    • Chen, Clara
    Publication type:
    Article

  • A case report of multiple primary prostate tumors with differential drug sensitivity.

    Published in:
    Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-14657-7
    By:
    • Wilkinson, Scott;
    • Harmon, Stephanie A.;
    • Terrigino, Nicholas T.;
    • Karzai, Fatima;
    • Pinto, Peter A.;
    • Madan, Ravi A.;
    • VanderWeele, David J.;
    • Lake, Ross;
    • Atway, Rayann;
    • Bright, John R.;
    • Carrabba, Nicole V.;
    • Trostel, Shana Y.;
    • Lis, Rosina T.;
    • Chun, Guinevere;
    • Gulley, James L.;
    • Merino, Maria J.;
    • Choyke, Peter L.;
    • Ye, Huihui;
    • Dahut, William L.;
    • Turkbey, Baris
    Publication type:
    Article